Company / Free Cash Flow per Share
4D Molecular Therapeutics, Inc. Free Cash Flow per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
-$3.02
FY2025
5-year range
-$3.02 / -$1.82
FY2021-FY2025
Trend
-65.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has fluctuated over the past 6 years, ranging from $-7.71 in FY2020 to $-1.82 in FY2024.
Based on SEC 10-K filings.
-3.02 in FY2025.
Remained stable around $-3.02 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow per share decreased 65.7% year-over-year.
- Peak free cash flow per share was recorded in FY2024.
- Lowest free cash flow per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.26 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.02 | -65.7% |
| FY2024 | -$1.82 | +39.4% |
| FY2023 | -$3.01 | -24.0% |
| FY2022 | -$2.43 | -24.8% |
| FY2021 | -$1.95 | +74.8% |
| FY2020 | -$7.71 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026